
    
      At the week 1 visit, the patients were vaccinated with a protein-conjugated vaccine against
      meningitis. All patients received a challenge at the month 6 visit with a low dose of meningo
      polysaccharide vaccine. A control group of healthy subjects (not suffering from atopic
      dermatitis) received only the vaccination and the challenge dose.
    
  